Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP and test guideline compliant study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
1,5-dimethyl-1-vinylhex-4-enyl isobutyrate
EC Number:
201-108-2
EC Name:
1,5-dimethyl-1-vinylhex-4-enyl isobutyrate
Cas Number:
78-35-3
Molecular formula:
C14H24O2
IUPAC Name:
1,5-dimethyl-1-vinylhex-4-enyl isobutyrate
impurity 1
Reference substance name:
Unknown impurities
Molecular formula:
not applicable
IUPAC Name:
Unknown impurities
Test material form:
liquid
Details on test material:
Sponsor's Identification: Linalyl Isobutyrate
Description: Colourless liquid
Chemical name: 3,7-Dimethyl-1,6-octadien-3-yl 2-methyl propanoate
Storage conditions: Approximately 4 °C in the dark

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
S9-fraction; S9 fraction prepared from liver homogenates of male Sprague-Dawley rats induced with three consecutive daily oral doses of phenobarbitone/β-naphthoflavone (80/100 mg/kg bw/day)
Test concentrations with justification for top dose:
Preliminary Toxicity Test:
- 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate in TA100 strain, with and without S9 mix using the direct plate incorporation method

Mutation Test- Experiment 1 (Range-finding Test):
- 100, 333, 1000, 2500 and 5000 µg/plate in all tester strains, with and without S9 mix using the direct plate incorporation method

Mutation Test- Experiment 2 (Main Test):
- 100, 333, 1000, 2500 and 5000 µg/plate in all tester strains, with and without S9 mix using the direct plate incorporation method

Vehicle / solvent:
Vehicle(s)/solvent(s) used: Dimethyl sulfoxide (DMSO)
- Justification for choice of solvent/vehicle: The test material was immiscible in sterile distilled water at 50 mg/mL but was fully miscible in DMSO at the same concentration in solubility checks performed in-house. DMSO was therefore selected as the vehicle.
- Test substance preparation: The test material was accurately weighed and approximate half-log dilutions prepared in DMSO by mixing on a vortex mixer on the day of each experiment. Formulated concentrations were adjusted to allow for the stated water/impurity content (1.6 %) of the test material. Prior to use, the solvent was dried using molecular sieves (sodium alumino-silicate) i.e., 2 mm pellets with a nominal pore diameter of 4 x 10^-4 microns.
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: N-ethyl-N'-nitro-N-nitrosoguanidine: 3 µg/plate for TA100 and 5µg/plate for TA1535; 9-Aminoacridine: 80 µg/plate for TA1537; 4-Nitroquinoline-1-oxide: 0.2 µg/plate for TA98; Mitomycin C: 0.5 µg/plate for TA102
Remarks:
without S9-mix
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-Aminoanthracene: 1 µg/plate for TA100, 2 µg/plate for TA1535 and TA1537; Benzo(a)pyrene: 5 µg/plate for TA98; 1,8-dihydroxyanthraquinone: 10 µg/plate for TA102
Remarks:
with S9-mix
Details on test system and experimental conditions:
SOURCE OF TEST SYSTEM: Salmonella typhimurium strains were obtained from the University of California at Berkeley on culture discs on 4 August 1995 and were stored at -196°C in a Statebourne liquid nitrogen freezer, model SXR 34.

METHOD OF APPLICATION: In agar (plate incorporation)

DURATION
- Incubation period: Plates were incubated at 37 °C for approximately 48 h

NUMBER OF REPLICATIONS:
- Preliminary Toxicity Test: Single plate/dose for treatment and vehicle control
- Experiment 1 (Range-finding Test) and Experiment 2 (Main Test): 3 plates/dose for treatment, vehicle and positive controls

DETERMINATION OF CYTOTOXICITY
- Method: Toxicity was determined by growth of the bacterial background lawn.

OTHER:
- Revertant colonies were counted using a Domino colony counter.
Evaluation criteria:
The test material may be considered positive in this test system if the following criteria are met:
The test material should have induced a reproducible, dose-related and statistically (Dunnett's method of linear regression (5)) significant increase in the revertant count in at least one strain of bacteria.
Statistics:
no data

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Under the test conditions, Linalyl Isobutyrate is not considered as mutagenic in S. typhimurium TA 1535, TA 1537, TA 98 and TA 100 & TA 102 strains.